Invivyd Announces Continued Neutralizing Activity of PEMGARDA™ (pemivibart) Against Currently Dominant SARS-CoV-2 Variant LP.8.1
New in vitro neutralization data show continued, consistent neutralizing activity of PEMGARDA™(pemivibart) against LP.8.1 Centers for Disease ...
Invivyd Announces Continued Neutralizing Activity of PEMGARDA (pemivibart) Against Currently Dominant SARS-CoV-2 Variant LP.8.1
New in vitro neutralization data show continued, consistent neutralizing activity of PEMGARDA (pemivibart) against LP.8.1 Centers for Disease Control reports LP.8.1, XEC and KP.3.1.1 together constitu ...
The American Journal of Managed Care16h
Trump’s Immigration Crackdown Fuels Health Crisis: Detention, Depression, Deportation, and Disease
Strict changes to immigration policies nationwide create a public health crisis in overcrowded detention centers, draining ...
Clinical Advisor20h
CDC: Vaccine Effectiveness Against COVID-19, Influenza Assessed for 2024-2025 Season
“Findings in this report show that vaccination with the 2024–2025 influenza vaccine reduced the likelihood of medically attended influenza and support CDC’s recommendation that all persons aged ≥6 ...